U.S. Retail REITs Stock News

Xylem (XYL) is drawing fresh attention after announcing two executive leadership changes effective July 1, 2026, appointments that could influence how investors think about its core Measurement and Control Solutions and Applied Water segments. See our latest analysis for Xylem. At a share price of US$121.21, Xylem has seen a 10.11% 30 day share price return but is still down 11.60% year to date. The 3 year total shareholder return of 13.65% suggests longer term holders have had a different...

After a strong three year total return of 85.0%, Invesco’s share price moves have pulled a lot of future expectations forward. The intrinsic value estimate from the Excess Returns model still points to room above the recent US$28.40 close, while the market based multiples look closer to “about right.” Over the past three years, Invesco has returned 85.0%. That puts more pressure on today’s buyers to judge whether that run already reflects much of the good news. Growing assets under...

AGNC Investment (AGNC) said its board declared a cash dividend of $0.12 per common share for July 2026, a key update for income focused investors watching the mortgage REIT’s payout stream. See our latest analysis for AGNC Investment. At a share price of $10.99, AGNC Investment’s recent pattern combines a 30 day share price return of 6.6% with a more modest 90 day gain of 3.29%. Its 1 year total shareholder return of 35.54% and 3 year total shareholder return of 67.45% indicate that longer...

Tootsie Roll Industries (TR) has drawn investor interest after recent share performance data showed the stock down about 1% over the past week, around 2% over the month, and roughly 12% over the past three months. See our latest analysis for Tootsie Roll Industries. Set against its longer history, Tootsie Roll Industries' recent share price softness contrasts with a positive year to date share price return of 10.59% and a 1 year total shareholder return of 10.96%. This suggests recent...

GE Vernova (GEV) has attracted fresh attention after outlining an $11b capex and R&D plan through 2028, paired with gas turbine demand linked to AI data centers and a new Chevron power partnership. See our latest analysis for GE Vernova. GE Vernova’s share price has pulled back recently, with a 1 day share price return of 4.49% down and a 7 day share price return of 9.5% down, following strong gains including a year to date share price return of 53.43% and a 1 year total shareholder return of...

Definium Therapeutics recently reported results from a large U.S. healthcare claims study, published in CNS Spectrums, examining real‑world pharmacotherapy patterns in adults with generalized anxiety disorder between 2020 and 2024. The analysis revealed frequent early discontinuation, rapid switching, and prolonged gaps in care, underscoring substantial unmet need and limited durability of benefit with current GAD treatment options. Next, we will explore how this evidence of high...

Eaton (NYSE:ETN) announced a $5.1 billion spin-off of its Mobility division, separating it from the rest of the business. The company entered a collaboration and investment agreement with VoltServer focused on next-generation power distribution. Eaton also formed a new partnership with FranklinWH targeting home energy management solutions. Dan T. Simpson was appointed president of Global Energy Infrastructure Solutions, adding new leadership to a core segment. Eaton, trading at $402.85, is...

Nucor’s share price has delivered a strong 178.7% total return over the past 5 years, while its current valuation signals indicate that the stock still screens as undervalued on both intrinsic value estimates and market multiples. A 178.7% return over 5 years suggests Nucor has already rewarded patient shareholders. Any further potential upside now matters more for new investors weighing entry price against risk. Expectations for Nucor’s future cash generation can support the current...

Bread Financial Holdings (BFH) is back in focus after announcing a planned leadership transition, with Executive Vice President and Chief Commercial Officer Valerie Greer set to retire and Dennis McCarthy stepping into a newly defined revenue role. See our latest analysis for Bread Financial Holdings. Bread Financial Holdings' latest leadership changes land at a time when momentum has cooled in the very short term, with the 7 day share price return down 6.12% and the 30 day share price return...

American Express (AXP) is back in the spotlight after a cluster of analyst upgrades tied to its card-focused business model, premium customer base, and co-branded Delta Air Lines partnership. See our latest analysis for American Express. Recent upgrades and fresh attention on American Express come as the stock trades at US$354.43, with a 30 day share price return of 8.91% and a 1 year total shareholder return of 11.62%. This indicates that momentum is building again after a weaker year to...

Sarepta Therapeutics (SRPT) is back in focus after the FDA accepted supplemental New Drug Applications for AMONDYS 45 and VYONDYS 53, a regulatory step that could influence how long these Duchenne muscular dystrophy therapies remain effective for patients. See our latest analysis for Sarepta Therapeutics. Sarepta Therapeutics’ latest regulatory progress comes after a mixed period for investors, with the share price currently at $18.82, a strong 30 day share price return of 22.93% but longer...

Hexcel has announced its participation in the July 2026 Farnborough International Airshow, where it will showcase NCAMP-qualified high-performance composite materials and meet aerospace, defense, and space customers and partners. A key insight is Hexcel’s plan to share new partnership announcements at the show, underlining how its integrated composites portfolio is becoming more embedded across next-generation aerospace platforms. We’ll now examine how Hexcel’s NCAMP-qualified material...

Morgan Stanley’s stock has almost tripled over the past five years, yet its current checks point to a company that screens as expensive on an intrinsic value basis while trading at roughly in line earnings multiples, raising the question of how much upside is already reflected in the US$221.09 share price. A roughly 191% return over five years puts Morgan Stanley among the stronger performers in large financials, which can leave less room for error if expectations reset. The shift toward...

Kimberly-Clark stock has slipped about 9.3% over the past year, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach indicates the shares may trade at a meaningful discount to that assessment of fair value. With recent headlines on the Arbex joint venture, a large Kenvue acquisition and renewed interest from institutional investors, the key tension is whether the current price reflects these changes or still leaves upside relative to the intrinsic value...

Rush Street Interactive (RSI) is back in focus after its BetRivers brand officially launched online casino and sportsbook operations in Alberta, its second major Canadian market entry, supported by strong app reviews and a tailored marketing push. See our latest analysis for Rush Street Interactive. That Alberta launch comes after a period of strong price momentum, with Rush Street Interactive’s share price delivering a 90 day return of 53.07% and a year to date share price return of 77.01%...

Virtu Financial (VIRT) issued preliminary earnings guidance for the quarter ended June 30, 2026, projecting net income of $285 million and basic and diluted earnings per share of $1.63. See our latest analysis for Virtu Financial. Virtu Financial's latest guidance lands after a strong run, with a 30-day share price return of 12.24% and a year-to-date share price return of 98.37%. The 3-year total shareholder return of 303.03% points to momentum that has been building over a longer horizon. If...

Infleqtion (INFQ) fell over 9% early this week as geopolitical tensions between the US and Iran weighed on markets, even as the company works to deploy US$100 million in recent government quantum computing funding. See our latest analysis for Infleqtion. At a share price of US$10.13, Infleqtion has seen its short term momentum weaken, with the share price down 9.31% over one day and 40.90% year to date. The 1 year total shareholder return is slightly positive at 0.20%, suggesting recent risk...

Northrop Grumman (NOC) recently recognized Qorvo with a 2026 Supplier Excellence Award for Strategic Excellence, highlighting how key suppliers support the company’s next generation aircraft, missile defense and space programs. See our latest analysis for Northrop Grumman. Despite the supplier recognition, Northrop Grumman’s recent share price momentum has eased, with the stock down over the past quarter while the 1-year total shareholder return of 5.6% and 5-year total shareholder return of...

Dividend affirmation and GLP-1 expansion set the tone CVS Health (CVS) has reaffirmed its quarterly dividend at $0.665 per share and expanded its GLP-1 support programs, while recent analyst actions and a fresh 52-week high have sharpened investor attention. See our latest analysis for CVS Health. At a share price of $105.90, CVS Health has delivered a strong 90 day share price return of 36.43% and a 1 year total shareholder return of 70.56%, suggesting momentum has been building around...

Cooling US inflation at 3.5% in June, a sharp jump in oil prices and a cautious Federal Reserve under Kevin Warsh have put big bank stocks back in focus. Higher energy costs could keep inflation pressure alive, while interest rate policy remains a key swing factor for funding costs, loan demand and margins across large US banks. This article looks at three stocks from a US Bank Stocks screener that stand out for their financial strength and market presence, and explains how exposure to these...

Jabil (JBL) has quickly moved back into focus after completing a US$902.24 million share repurchase and then filing a broad shelf registration that could support future capital raising across several security types. See our latest analysis for Jabil. Despite the recent shelf filing and completion of the US$902.24 million buyback, Jabil’s share price has pulled back, with the latest 30 day share price return down 16.33%. However, the year to date share price return of 33.93% and very large 5...

Exelixis stock has already delivered a very strong 243.8% return over the past 5 years, yet valuation checks still flag it as looking cheap on several measures, so investors are weighing whether the market is still underpricing the business or already baking in much of the oncology opportunity. A 243.8% 5 year return puts Exelixis firmly in the group of biotech stocks that have already rewarded patient holders, which naturally raises the bar for any new entry point. Upcoming regulatory...

Pfizer stock sits in an awkward middle ground for valuation right now, with a roughly 21% share price decline over five years set against checks that suggest the current price looks neither clearly cheap nor clearly expensive. Over the past five years, Pfizer shares have declined about 21%, which means long term holders have not been rewarded for their patience so far. Regulatory progress in areas like oncology and weight loss can support higher earnings expectations, while ongoing pricing...

Intel (NasdaqGS:INTC) announced a €5b expansion of its Leixlip, Ireland campus. The project is aimed at increasing output of next generation AI and data center chips, including Intel Xeon 6 and future Xeon processors. The upgraded facilities are planned to use Intel 3 node technology for advanced server products. The investment is positioned as part of Intel's broader manufacturing and foundry transformation in Europe. For investors watching the buildout of AI computing capacity, Intel is...